Frankfurt - Delayed Quote EUR
Crinetics Pharmaceuticals, Inc. (6Z4.F)
27.80
+0.20
+(0.72%)
At close: May 16 at 9:05:11 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
760
1,039
4,013
4,737
1,078
Operating Expense
377,490
339,893
226,621
172,619
108,780
Operating Income
-376,730
-338,854
-222,608
-167,882
-107,702
Net Non Operating Interest Income Expense
48,949
41,435
13,436
4,317
157
Other Income Expense
-471
-989
-5,357
-353
-96
Pretax Income
-328,252
-298,408
-214,529
-163,918
-107,641
Net Income Common Stockholders
-328,252
-298,408
-214,529
-163,918
-107,641
Diluted NI Available to Com Stockholders
-328,252
-298,408
-214,529
-163,918
-107,641
Basic EPS
-3.80
-3.69
-3.69
-3.15
-2.80
Diluted EPS
-3.80
-3.69
-3.69
-3.15
-2.80
Basic Average Shares
85,986.25
80,783
58,071
51,982
38,436
Diluted Average Shares
85,986.25
80,783
58,071
51,982
38,436
Total Operating Income as Reported
-376,730
-338,854
-222,608
-167,882
-107,702
Total Expenses
377,490
339,893
226,621
172,619
108,780
Net Income from Continuing & Discontinued Operation
-328,252
-298,408
-214,529
-163,918
-107,641
Normalized Income
-328,252
-298,408
-214,529
-164,518
-107,641
Interest Income
48,949
41,435
13,436
4,317
157
Net Interest Income
48,949
41,435
13,436
4,317
157
EBIT
-376,730
-338,854
-222,608
-167,882
-107,702
EBITDA
-373,494
-336,069
-221,510
-166,899
-106,780
Reconciled Depreciation
3,236
2,785
1,098
983
922
Net Income from Continuing Operation Net Minority Interest
-328,252
-298,408
-214,529
-163,918
-107,641
Total Unusual Items Excluding Goodwill
--
--
--
600
--
Total Unusual Items
--
--
--
600
--
Normalized EBITDA
-373,494
-336,069
-221,510
-167,499
-106,780
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/23/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade